{"id":"NCT01597622","sponsor":"GlaxoSmithKline","briefTitle":"BEL114333, a Continuation Study of BEL113750 in Subjects With Systemic Lupus Erythematosus (SLE) in Northeast Asia, and in Japan Subjects Completing the Open-label Extension of HGS1006-C1115","officialTitle":"BEL114333, a Multicenter, Continuation Study of Belimumab in Subjects With Systemic Lupus Erythematosus (SLE) Who Completed the Phase III Study BEL113750 in Northeast Asia or Completed the Open-label Extension of HGS1006-C1115 in Japan","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-06-11","primaryCompletion":"2018-09-13","completion":"2018-09-13","firstPosted":"2012-05-14","resultsPosted":"2020-01-09","lastUpdate":"2020-03-27"},"enrollment":142,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Systemic Lupus Erythematosus"],"interventions":[{"type":"DRUG","name":"Belimumab","otherNames":[]}],"arms":[{"label":"Open-label Belimumab","type":"EXPERIMENTAL"}],"summary":"This study provides subjects who complete the BEL113750 study and subjects who complete the open-label extension of HGS1006-C1115 (referred to as C1115) Study in Japan the option of continuing treatment with belimumab (10 mg/kg intravenously every 4 weeks) for those randomized to belimumab, or the option to begin treatment with belimumab for those randomized to placebo, as an add-on to their standard of care SLE therapy.","primaryOutcome":{"measure":"Number of Participants With Adverse Events (AEs) and Serious AEs (SAEs)","timeFrame":"Up to 6 calendar years and 9 months","effectByArm":[{"arm":"Open-label Belimumab 10 mg/kg","deltaMin":48,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":2},"locations":{"siteCount":27,"countries":["Japan","South Korea"]},"refs":{"pmids":["34215703"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":48,"n":142},"commonTop":["Nasopharyngitis","Headache","Cough","Viral upper respiratory tract infection","Herpes zoster"]}}